-
To promote the transformation and upgrading of Chinese medicine industry, we need to grasp the following 3 points
Time of Update: 2020-07-15
" Pharmaceutical Network Industry Dynamic " Data show that since 2020 the of Chinese herbal medicine sand In the first quarter, China's exports of Chinese herbal medicines and traditional Chinese
-
Drug maker's latest ranking sits as Roche replaces Pfizer
Time of Update: 2020-07-14
Pharmaceutical Network July 6th, pharmaceutical companies ranking shuffle came 1 , pharmaceutical companies ranking shuffling, Roche replaced Pfizer recently, the United States "Pharmaceutical M
-
Yangzijiang Pharmaceutical Co., D., production and sales double over 70 billion
Time of Update: 2020-06-11
Pharmaceutical network January 4 reporter son was informed that Yangzijiang pharmaceutical profits and taxes for 25 consecutive years to maintain double-digit growth, the Group in 2017 accumulated out
-
The 68th National Drug Fair (Guangzhou) is about to open
Time of Update: 2020-06-04
Business Agency, November 21 December 4-6, 2012, the 68th National Pharmaceutical Fair (PHARMCHINA) will be held in Guangzhou-China Import and Export Commodity Fair Exhibition Hall (Zhangzhou
-
The principle of purchasing - all from the perspective of supply chain cost
Time of Update: 2020-02-21
Basic information to be considered in purchase analysis includes cost analysis of purchased materials, delivery time and place, payment term of transaction, etc Cost analysis is the most important par
-
Analysis of competition pattern of domestic microsphere / liposome research and development enterprises
Time of Update: 2020-01-30
Abstract: for the pharmaceutical companies that have already launched microspheres / lipid system products, such as Lizhu group, Beijing Bonte, LVYE pharmaceutical, Shiyao group, Beijing Taide, Fudan
-
37 pharmaceutical companies enter the top 500 listed companies in China
Time of Update: 2020-01-09
Recently, the latest list of China's top 500 listed companies by market value in 2020 was released According to the statistics of 21 data news laboratory, as of January 1, 2020, there are 7343 Chinese
-
The biggest winner of consistency evaluation in 2019: Qilu pharmaceutical
Time of Update: 2020-01-07
Original: vernacular According to pharmago database, there are 6 enterprises that have passed the consistency evaluation in 2019, including Qilu pharmaceutical, Yangzi River, Shiyao group, Zhengda Tia
-
Donafinil in the first-line treatment of advanced HCC stage III
Time of Update: 2020-01-02
Original: Xiangdong On the first day of 2020, Suzhou Zejing biopharmaceutical Co., Ltd announced a big news It announced the success of donafenib in the phase III clinical study (trial code zgdh3) of
-
Wang Yi, general manager of sina.com business center
Time of Update: 2019-12-28
On December 28, 2019, under the guidance of China Pharmaceutical Materials Association, the "2019 China Pharmaceutical New Smart exchange forum" jointly sponsored by Sina pharmaceutical and China Phar
-
The next PD-1, Nobel Laureate of "blood and oxygen" opens up a new direction of anti-cancer treatment
Time of Update: 2019-10-21
In recent years, the PD-1 fire has made many pharmaceutical enterprises taste the sweetness of new drug research and development, and at the same time, they are always exploring the next "PD-1" As a p
-
Good news from a group of pharmaceutical companies that passed the FDA's on-site inspection
Time of Update: 2019-07-03
[pharmaceutical Station industry trends] at present, while a batch of pharmaceutical products have been approved by the FDA, there are also a batch of enterprises that have received good news of passi
-
21 rare disease drugs welcome tax cuts, open space for drug price cuts
Time of Update: 2019-02-22
Pharmaceutical Network February 22nd, the State Council executive meeting held before the decision to give vat on rare diseasedrugs More than 20 million patients with rare diseases should be protected
-
Industry: China's drug price reduction may copy the Japanese model
Time of Update: 2019-01-22
[China Pharmaceutical network industry trends] at present, the "4 + 7" pilot program for centralized procurement has been announced, and Liaoning recently released the pilot volume purchase and sale c
-
Kangmei, Hengrui, Shanghai Pharmaceutical and other pharmaceutical enterprises have handed in their transcripts
Time of Update: 2018-10-31
After September, it's time for companies to disclose their performance statements As of October 29, according to incomplete statistics of local medical stations, 190 A-share listed pharmaceutical comp
